Report: Workshop on mediastinal grey zone lymphoma

European Journal of Haematology, Supplement

Volumn 75, Issue 66, 2005, Pages 45-52

  Poppema, Sibrand ^a   Kluiver, Joost L ^a   Atayar, Cigdem ^a   Van Berg, Anke Den ^a   Rosenwald, Andreas ^b   Hummel, Michael ^c   Lenze, Dido ^c   Lammert, Hetty ^c   Stein, Harald ^c   Joos, Stephan ^d   Barth, Thomas ^e   Dyer, Martin ^f   Lichter, Peter ^d   Klein, Uwe ^g   Cattoretti, Giorgio ^g   Gloghini, Annunziata ^h   Tu, Yuhai ^g,i   Stolovitzky, Gustavo A ^g,i   Califano, Andrea ^h   Carbone, Antonino ^h   Dalla Favera, Ricardo ^g   Melzner, Ingo ^e   Bucur, Alexandra J ^e   Bruderlein, Silke ^e   Dorsch, Karola ^e   Hasel, Cornelia ^e   Barth, Thomas F E ^e   Leithäuser, Frank ^e   Möller, Peter ^e   more..

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e UNIVERSITY OF ULM   (Germany)

^f MRC TOXICOLOGY UNIT   (United Kingdom)

^g Och Spine at New York Presbyterian Hospitals   (United States)

^h CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

ⁱ IBM T J WATSON RESEARCH CENTER   (United States)

Author keywords

Classical hodgkin lymphoma; Gene expression profiling; Mediastinal grey zone lymphoma; Primary mediastinal B cell lymphoma; REL; TARC

Indexed keywords

GENE PRODUCT; INTERLEUKIN 13 RECEPTOR; JANUS KINASE 2; PROTEIN TYROSINE KINASE; STAT5 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

B CELL LYMPHOMA; CARCINOGENESIS; CELL TYPE; CONFERENCE PAPER; CYTOKINE RELEASE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE JAK2; GENETIC ANALYSIS; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MEDIASTINUM LYMPH NODE; MULTIPLE MYELOMA; NONHUMAN; ONCOGENE; PATHOGENESIS; PRIMARY MEDIASTINAL B CELL LYMPHOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ARTICLE; B LYMPHOCYTE; CHROMOSOME ABERRATION; COMPARATIVE STUDY; EDUCATION; GENETICS; MEDIASTINUM TUMOR; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

B-LYMPHOCYTES; CHROMOSOME ABERRATIONS; EDUCATION; GENE EXPRESSION REGULATION, LEUKEMIC; HODGKIN DISEASE; HUMANS; LYMPHOMA, B-CELL; MEDIASTINAL NEOPLASMS;

EID: 21044432825     PISSN: 09024506     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. RUDIGER T, JAFFE ES, DELSOL G, et al. Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma). Ann Oncol 1998;9:S31-S38.
2. CALVO KR, TRAVERSE-GLEHEN A, PITTALUGA S, JAFFE ES. Molecular profiling provides evidence of primary mediastinal large B-cell lymphoma as a distinct entity related to classic Hodgkin lymphoma: implications for mediastinal gray zone lymphomas as an intermediate form of B-cell lymphoma. Adv Anat Pathol 2004;11:227-238.
3. ROSENWALD A, WRIGHT G, LEROY K, et al. Molecular diagnosis of primary mediastinal B-cell lymphoma identifies a clinically favorable subgroup of diffuse large B-cell lymphoma related to Hodgkin lymphoma. J Exp Med 2003;198:851-862.
4. ROSENWALD A, WRIGHT G, CHAN WC, et al. Lymphoma/ Leukemia Molecular Profiling Project. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. New Engl J Med 2002;346:1937-1947.
5. COPIE-BERGMAN C, PLONQUET A, ALONSO MA, BOULLAND ML, MARQUET J, DIVINE M, MOLLER P, LEROY K, GAULARD P. MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas. Mod Pathol 2002;15:1172-1180.
6. COPIE-BERGMAN C, BOULLAND ML, DEHOULLE C, MOLLER P, FARCET JP, DYER MJ, HAIOUN C, ROMEO PH, GAULARD P, LEROY K. Interleukin 4-induced gene 1 is activated in primary mediastinal large B-cell lymphoma. Blood 2003; 101:2756-2761.
7. LODDENKEMPER C, ANAGNOSTOPOULOS I, HUMMEL M, JOHRENS-LEDER K, Foss HD, JUNDT F, WIRTH T, DORKEN B, STEIN H. Differential Emu enhancer activity and expression of BOB. 1/OBF. 1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas. J Pathol 2004; 202:60-69.
8. STEIN H, MARAFIOTI T, Foss HD, LAUMEN H, HUMMEL M, ANAGNOSTOPOULOS I, WIRTH T, DEMEL G, FALINI B. Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood 2001;97:496-501.
9. SAVAGE K, MONTI, S, KUTOK JL, et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin's lymphoma. Blood 2003;102:3871-3879.
10. VAN DEN BERG A, VISSER L, POPPEMA S. High expression of CC chemokine TARC in the Reed-Sternberg cells: a possible explanation for the characteristic lymphocytic infiltrate in Hodgkin's disease. Am J Pathol 1999;154: 1685-1691.
11. VAN DEN BERG A, KROESEN BJ, KOOISTRA K, et al. High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma. Genes Chromosomes Cancer 2003;37:20-28.
12. JOOS S, OTANO-JOOS MI, ZIEGLER S, BRÜDERLEIN S, DU MANOIR S, BENTZ M, MÖLLER P, LICHTER P. Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and of the REL gene. Blood 1996;87:1571-1578.
13. BENTZ M, BARTH TFE, BRÜDERLEIN S, et al. Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma - a comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line. Genes Chromosom Cancer 2001;30:393-401.
14. JOOS S, KÜPPER M, OHL S, et al. Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells. Cancer Res 2000;60:549-552.
15. JOOS S, MENZ CK, SIEBERT R, et al. Classical Hodgkin's lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2. Blood 2002;99:1381-1387.
16. JOOS S, GRANZOW M, HOLTGREVE-GREZ H, et al. Hodgkin lymphoma cell lines are characterized by frequent aberrations on chromosome 2p and 9p including REL and JAK. Int J Cancer 2003;103:489-495.
17. BARTH TFE, MARTIN-SUBERO JI, JOOS S, et al. Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin's lymphoma. Blood 2003;101:3681-3686.
18. SKINNIDER BF, ELIA AJ, GASCOYNE RD, PATTERSON B, TRUMPER L, KAPP U, MAK TW. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 2002;99:618-626.
19. GUITER C, DUSANTER-FOURT I, COPIE-BERGMAN C, BOULLAND ML, LE GO S, GAULARD P, LEROY K, CASTELLANO P. Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma. Blood 2004;104:543-549.
20. KLEIN U, GLOGHINI A, GAIDANO G, CHADBURN A, CESARMAN E, DALLA-FAVERA R, CARBONE A. Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. Blood 2003;101:4115-4121.
21. KÜPPERS R, KLEIN U, SCHWERING I, et al. Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling. J Clin Invest 2003;111:529-537.
22. FALINI B, FIZZOTTI M, PUCCIARINI A, et al. A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B-cells, plasma cells, and activated T cells. Blood 2000;95:2084-2092.
23. ANGELIN-DUCLOS C, CATTORETTI G, LIN KI, CALAME K. Commitment of B lymphocytes to plasma cell fate is associated with BLIMP-1 expression in vivo. J Immunol 2000; 165:5462-5471.
24. MELZNER I, BUCUR AJ, BRÜDERLEIN S, DORSCH K, HASEL C, BARTH TF, LEITHÄUSER F, MÖLLER P. Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phos-pho-JAK2 action in MedB-1 mediastinal lymphoma line. Blood 2005;105:2535-2542.
25. WORMALD S, HILTON DJ. Inhibitors of cytokine signal transduction. J Biol Chem 2000;279:821-824.
26. ZHANG JG, FARLEY A, NICHOLSON SE, et al. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc Natl Acad Sci USA 1999;96:2071-2076.
27. CHIM CS, WONG KY, LOONG F, SRIVASTAVA G. SOCS1 and SHP1 hypermethylation in mantle cell lymphoma and follicular lymphoma: implications for epigenetic activation of the Jak/STAT pathway. Leukemia 2004; 18:356-358.